EMEA-001623-PIP03-20-M01
Key facts
| Active substance |
Finerenone
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0365/2022
|
| PIP number |
EMEA-001623-PIP03-20-M01
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of heart failure
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Bayer AG
Tel. +49 202364913 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|